115 related articles for article (PubMed ID: 1376022)
1. Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters.
Scopsi L; Andreola S; Pilotti S; Testori A; Baldini MT; Leoni F; Lombardi L; Hutton JC; Shimizu F; Rosa P
Am J Surg Pathol; 1992 Jun; 16(6):561-76. PubMed ID: 1376022
[TBL] [Abstract][Full Text] [Related]
2. Argyrophilic carcinoma of the male breast. A neuroendocrine tumor containing predominantly chromogranin B (secretogranin I).
Scopsi L; Andreola S; Saccozzi R; Pilotti S; Boracchi P; Rosa P; Conti AR; Manzari A; Huttner WB; Rilke F
Am J Surg Pathol; 1991 Nov; 15(11):1063-71. PubMed ID: 1928556
[TBL] [Abstract][Full Text] [Related]
3. Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation.
Scopsi L; Andreola S; Pilotti S; Bufalino R; Baldini MT; Testori A; Rilke F
Am J Surg Pathol; 1994 Jul; 18(7):702-11. PubMed ID: 8017565
[TBL] [Abstract][Full Text] [Related]
4. Argyrophilic neuroendocrine carcinoma of the male breast.
Papotti M; Tanda F; Bussolati G; Pugno F; Bosincu L; Massareli G
Ultrastruct Pathol; 1993; 17(1):115-21. PubMed ID: 8427027
[TBL] [Abstract][Full Text] [Related]
5. Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas.
Rosa P; Bassetti M; Weiss U; Huttner WB
J Histochem Cytochem; 1992 Apr; 40(4):523-33. PubMed ID: 1552186
[TBL] [Abstract][Full Text] [Related]
6. A study of different markers for neuroendocrine differentiation in breast carcinomas.
Nesland JM; Holm R; Johannessen JV
Pathol Res Pract; 1986 Oct; 181(5):524-30. PubMed ID: 2431399
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.
Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G
Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862
[TBL] [Abstract][Full Text] [Related]
9. Breast carcinomas with neuroendocrine differentiation.
Nesland JM; Memoli VA; Holm R; Gould VE; Johannessen JV
Ultrastruct Pathol; 1985; 8(2-3):225-40. PubMed ID: 4060259
[TBL] [Abstract][Full Text] [Related]
10. The nature of breast dense core granules: chromogranin reactivity.
Battersby S; Dely CJ; Hopkinson HE; Anderson TJ
Histopathology; 1992 Feb; 20(2):107-14. PubMed ID: 1313781
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase.
Rasmuson T; Grankvist K; Roos G; Ljungberg B
Acta Oncol; 1999; 38(5):623-8. PubMed ID: 10427952
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation is a common feature of thymic carcinoma.
Lauriola L; Erlandson RA; Rosai J
Am J Surg Pathol; 1998 Sep; 22(9):1059-66. PubMed ID: 9737237
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid.
Schmid KW; Fischer-Colbrie R; Hagn C; Jasani B; Williams ED; Winkler H
Am J Surg Pathol; 1987 Jul; 11(7):551-6. PubMed ID: 3300386
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers.
Ueda G; Shimizu C; Shimizu H; Saito J; Tanaka Y; Inoue M; Tanizawa O
Gynecol Oncol; 1989 Aug; 34(2):164-9. PubMed ID: 2473948
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
[TBL] [Abstract][Full Text] [Related]
19. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
20. Endocrine markers in argyrophilic carcinomas of the breast.
Bussolati G; Papotti M; Sapino A; Gugliotta P; Ghiringhello B; Azzopardi JG
Am J Surg Pathol; 1987 Apr; 11(4):248-56. PubMed ID: 2436494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
